CubeSmart vs Sabra Health Care REIT
CUBE and SBRA side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CUBE and SBRA compare
CubeSmart is the larger company, worth 1.9 times as much as Sabra Health Care REIT ($10.1B against $5.4B).
On earnings, CubeSmart is cheaper: it trades at 29.9× trailing earnings, against 74.9× for Sabra Health Care REIT.
Sabra Health Care REIT grew revenue faster over the last twelve months (23.4% versus 3.3% for CubeSmart).
Both pay dividends: CubeSmart yields 4.7% and Sabra Health Care REIT 5.7%.
CubeSmart scores higher on the StockData Score (9 against 6 for Sabra Health Care REIT), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CUBE | SBRA |
|---|---|---|
| Size and price | ||
| Market cap | $10.1B | $5.4B |
| Share price | $45.14 | $20.97 |
| Change, 1 year | 23.2% | 9.9% |
| Change, 5 years | −17.7% | 47.5% |
| Beta (5Y) | 0.81 | 0.46 |
| Employees | 3,121 | 58 |
| StockData Score | ||
| Total score | 9 (better) | 6 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 0 | 2 (better) |
| Health score | 4 (better) | 0 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 29.9× (better) | 74.9× |
| P/S | 8.8× | 5.8× (better) |
| P/B | 4.1× | 1.9× (better) |
| EV/EBITDA | – | 13.1× |
| PEG | 7.10 | – |
| Fair value | $35.87 | $13.09 |
| Margin of safety | −25.8% (better) | −60.2% |
| Growth | ||
| Revenue growth (TTM) | 3.3% | 23.4% (better) |
| Revenue growth, 5Y average | 10.6% (better) | 5.3% |
| Net income growth (TTM) | – | −59.2% |
| EPS growth (TTM) | −3.2% (better) | −61.1% |
| EPS growth, 5Y average | 11.4% (better) | −0.91% |
| Profitability | ||
| Gross margin | 67.6% | – |
| Net margin | – | 7.8% |
| Return on equity | – | 2.5% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Altman Z-score | 1.29 | 1.41 (better) |
| Piotroski F-score | – | 6 |
| Dividends and buybacks | ||
| Dividend yield | 4.7% | 5.7% (better) |
| Payout ratio | – | 423% |
| Years of dividend growth | 16 (better) | 0 |
| Dividend growth, 5Y average | 9.5% (better) | −2.3% |
| Buyback yield | 0.00% | – |
| Shareholder yield | 4.7% | 5.7% (better) |
| Ownership | ||
| Held by institutions | 103% | 102% |
| Held by insiders | 0.88% | 1.9% |
| Insider net buying, 12 months | −$9.9M | −$4.5M (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 3.7% | 7.1% |
Go deeper
- CUBE stock overview
- CUBE income statement
- CUBE valuation and score
- SBRA stock overview
- SBRA income statement
- SBRA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.